Lexpos News

MHRA Class 4 Medicines Defect Information: Mycophenolate Mofetil 1g/5ml Oral Suspension (Rosemont Pharmaceuticals Limited) Drug alert number: EL (24)A/59 Date issued: 2 December 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Mycophenolate Mofetil 1g/5ml Oral Suspension (Rosemont Pharmaceuticals Limited) DMRC reference number: DMRC-33616486 Company name: [...]

The post MHRA Class 4 Medicines Defect Information: Mycophenolate Mofetil 1g/5ml Oral Suspension (Rosemont Pharmaceuticals Limited) appeared first on Community Pharmacy England.

Pharmacy owners have just over a week left to complete the 2024 workforce survey, which is a mandatory requirement for all pharmacy owners. Read more about the survey and how to complete it The NHS Business Services Authority sent an email to pharmacy owners containing a link to the survey in October. In some cases, [...]

The post Just over a week left to complete the 2024 mandatory workforce survey appeared first on Community Pharmacy England.

NHS England is inviting community pharmacy owners and teams to take part in user research interviews on pharmacy IT. These virtual sessions will last approximately 25-40 minutes and provide an opportunity for you to share your views and requests. Separate research teams are exploring several key areas, including: NHSmail and Microsoft 365 features: Provide feedback [...]

The post Can you help with user research about pharmacy IT? appeared first on Community Pharmacy England.

Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (29/11/2024) announced the following list of price concessions for November 2024: This is not the final update for November. We are still working with the DHSC to agree [...]

The post November 2024 Price Concessions 4th Update appeared first on Community Pharmacy England.

Increases to employers National Insurance contributions and the National Living Wage will cost community pharmacies £200 million a year in unplanned costs, national pharmacy bodies including Community Pharmacy England have warned today. They have told the Government that ‘without mitigation, these additional costs will push many pharmacies more towards insolvency’, leading even more to close [...]

The post Budget to cost pharmacies £200 million without mitigation, pharmacy bodies warn appeared first on Community Pharmacy England.